loadpatents
Patent applications and USPTO patent grants for Colman; Peter Malcolm.The latest application filed is for "apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases".
Patent | Date |
---|---|
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,952,157 - Ding , et al. February 10, 2 | 2015-02-10 |
Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same Grant 8,686,110 - Colman , et al. April 1, 2 | 2014-04-01 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140066621 - Bruncko; Milan ;   et al. | 2014-03-06 |
Benzothiazole Compounds App 20100197711 - Watson; Keith Geoffrey ;   et al. | 2010-08-05 |
Therapeutic Pro-apoptotic Bh3-like Molecules And Methods For Generating And/or Selecting The Same App 20090048164 - Colman; Peter Malcolm ;   et al. | 2009-02-19 |
Target binding polypeptide Grant 5,844,094 - Hudson , et al. December 1, 1 | 1998-12-01 |
Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents Grant 5,648,379 - Von Itzstein , et al. July 15, 1 | 1997-07-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.